Oversea-Chinese Banking Corp - Ltd Outlook eases along with front-loaded allowances

12 Aug 2020
  • 2Q20 earnings was below our expectations by 10% on lower NII (-9% YoY) and higher than expected allowances booked for the quarter.
  • Non-interest income lifts (+11% YoY) sluggish NII with recovery in market conditions benefiting shareholders’ funds and investment holdings from GEH.
  • Credit cost of 91 bps in 2H20 will likely ease over next two years to 50 – 60 bps previously guided by the bank.
  • Scrip dividend option at 10% discount will be available for revised semi-annual dividend of S$0.159 per share.
  • We maintain ACCUMULATE at a lower target price of S$8.92. (previously S$9.14). Earnings was revised downwards by compressing NIM by a further 5 bps to reflect a prolonged weak interest rate environment.

 

The Positives

+ Non-interest income grew 11% YoY to S$1.14bn from S$1.03bn in 2Q20 despite poorer fee performance (-16% YoY).

Insurance income and trading income grew 50% and 31% YoY in 2Q20 from S$188mn and S$320mn to S$282mn and S$420mn respectively due to a strong capital market performance in the second quarter. This attributed to a better shareholders’ fund performance within the insurance income and led to reversal of MTM losses in 2Q20 from 1Q20.

 

The Negatives

– NII fell 9% YoY on a 19 bps NIM compression despite loans growth of 2% YoY.

NIM fell from 1.79% to 1.60% YoY in 2Q20 on interest rate cuts. Second quarter exit NIM of 1.55% will likely see some recovery in 2H20 with asset and deposit re-pricing in subsequent quarters to bring full year NIM between 1.55% – 1.60%, roughly a further 10 bps NIM compression from 1.68% observed in 1H20.

– Write-down of OSV loan book contributed to higher levels of allowances.

OCBC maintains a poor outlook on the OSV sector as muted economic activity will see weakness in demand for the sector that is not likely to recover over the next year. The bank has recorded S$518mn in SP for 2Q20 to bring the sector loan apart from reputable national oil majors down to 0.3% of book value.

Guidance of 100 – 130 bps in credit costs taken over two years remain intact with heightened credit cost of 91 bps recorded in 1H20 will likely see additional allowances undertaken in subsequent quarters reduced to normalised levels.

 

Outlook

Semi-annual dividend of S$0.159 per share dampens yield attractiveness.

Revised dividend of S$0.159 per share represents a forward dividend for FY20 of S$0.318 per share which is 43% below previous dividend expectation of S$0.56 per share due to a 40% cut from FY19 dividend of S$0.53 as stipulated by MAS.

Scrip dividend will be available at a 10% discount to keep scrip dividend policy intact from recent scrip dividend option provided by the bank despite strong capital position with CET-1 ratio at 14.2%.

 

Application for loan moratorium in Singapore tapers at lower than expected uptake.

Loan moratorium extended in Singapore represents between 6-7% of loan book value which is below half of the 15% previously expected by bank. 96% of the loans are secured and will ease pressure on NPL formation in subsequent quarters after loan moratorium expires.

 

Investment Actions

We maintain ACCUMULATE at a lower target price of S$8.92 (previously S$9.14). We revise our TP downwards after lowering NIM estimates by a further 5 bps. FY21 earnings is expected to recover to normalised levels after more allowances were booked in 1H20.

Contact us to Open an Account

Need Assistance? Share your Details and we’ll get back to you

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com